{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:09:42Z","timestamp":1788775782093,"version":"build-2803163510"},"reference-count":12,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"DOI":"10.1002\/jpn3.70563","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:32:36Z","timestamp":1788773556000},"source":"Crossref","is-referenced-by-count":0,"title":["Best practices for prior authorization in pediatric inflammatory bowel disease: A practical multidisciplinary roadmap"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-4885","authenticated-orcid":false,"given":"Brad D.","family":"Constant","sequence":"first","affiliation":[{"name":"Department of Pediatrics Digestive Health Institute, Children's Hospital Colorado University of Colorado School of Medicine Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McNicol","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Nationwide Children's Hospital Columbus Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeron","family":"Speaks","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Levine Children's Hospital, Atrium Health Specialty Pharmacy Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3122-5214","authenticated-orcid":false,"given":"Shannon","family":"Dodge","sequence":"additional","affiliation":[{"name":"Dayton Children's Hospital Cedarville University Dayton Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1742-936X","authenticated-orcid":false,"given":"Hilary K.","family":"Michel","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital Columbus Ohio USA"},{"name":"The Ohio State University College of Medicine Columbus Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"3","key":"e_1_2_8_2_1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052501","article-title":"Delays related to prior authorization in inflammatory bowel disease","volume":"149","author":"Constant BD","year":"2022","journal-title":"Pediatrics"},{"key":"e_1_2_8_3_1","article-title":"The costs of inflammatory bowel disease and the financial impact of insurance delays","author":"Bhat S","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker\u2010stratified comparison of top\u2010down versus accelerated step\u2010up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open\u2010label randomised controlled trial","volume":"9","author":"Noor NM","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MPG.0000000000003564","article-title":"Denials, dilly\u2010dallying, and despair: navigating the insurance labyrinth to obtain medically necessary medications for pediatric inflammatory bowel disease patients","volume":"75","author":"Kahn SA","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40271-015-0126-z","article-title":"Novel statistical approach to determine inflammatory bowel disease: patients' perspectives on shared decision making","volume":"9","author":"Siegel CA","year":"2016","journal-title":"Patient"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/PPA.S133222","article-title":"Shared decision\u2010making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs","volume":"11","author":"Lofland J","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otab047","article-title":"There is no substitute for effective education about biosimilars","volume":"3","author":"Maltz RM","year":"2021","journal-title":"Crohn's Colitis 360"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ibd\/izab110","article-title":"Increasing biosimilar utilization at a pediatric inflammatory bowel disease center and associated cost savings: show me the money","volume":"28","author":"Morris GA","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.japh.2022.07.011","article-title":"Evaluation of the fast prior authorization technology highway","volume":"62","author":"Clayton D","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/jamia\/ocad258","article-title":"Efficient healthcare with large language models: optimizing clinical workflow and enhancing patient care","volume":"31","author":"Tripathi S","year":"2024","journal-title":"J Am Med Inform Assoc"},{"key":"e_1_2_8_12_1","first-page":"815","article-title":"Advancing patient care through specialty pharmacy services in an academic health system","volume":"23","author":"Bagwell A","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000808","article-title":"Higher rates of delay in starting advanced inflammatory bowel disease therapies linked to insurance delays, intravenous infusions, and lack of pharmacy support","volume":"16","author":"Gottesman S","year":"2025","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70563","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jpn3.70563","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:32:38Z","timestamp":1788773558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jpn3.70563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":12,"alternative-id":["10.1002\/jpn3.70563"],"URL":"https:\/\/doi.org\/10.1002\/jpn3.70563","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"jpn3.70563"}}